Highbridge Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Highbridge Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-86	Closed	-$58K	–	1733
2015 Q1	$58K	Buy	86 +3	+4%	+$1.98K	﹤0.01%	1336
2014 Q4	$44K	Sell	83 -1,462	-95%	-$731K	﹤0.01%	1125
2014 Q3	$920K	Buy	1,545 +1,430	+1,243%	+$989K	0.01%	692
2014 Q2	$75K	Sell	115 -654	-85%	-$433K	﹤0.01%	1013
2014 Q1	$604K	Sell	769 -213	-22%	-$173K	0.01%	663
2013 Q4	$756K	Buy	+982	New	+$741K	0.01%	590
2013 Q3	–	Sell	-113	Closed	-$98K	–	1576
2013 Q2	$98K	Buy	+113	New	+$95.5K	﹤0.01%	1241

Other funds holding MTEM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Highbridge Capital Management's MTEM Position: Q2 2015 in Review

Highbridge Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q2 2015, closing a stake of 86 shares — an estimated $58K sold.

Highbridge Capital Management first reported a position in MTEM in Q2 2013 and held it in 7 quarters. The position peaked at $920K in Q3 2014. 85 funds tracked by Wall St. Rank hold MTEM as of Q2 2015.

Highbridge Capital Management reported no remaining Molecular Templates, Inc. position as of Q2 2015 after selling out during the quarter.
Highbridge Capital Management sold 86 Molecular Templates, Inc. shares in Q2 2015, an estimated $58K.
Highbridge Capital Management first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 7 quarters.
Highbridge Capital Management's Molecular Templates, Inc. position peaked at $920K in Q3 2014.
85 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2015.

Based on Highbridge Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.